Home : Unsafe Drugs : Vytorin : News Articles

Vytorin - News Articles

EARNINGS PREVIEW: US Drug Makers Expected To See Uptick - WSJ.com: The company has seen continued strong sales for its biggest drug, asthma and allergy treatment Singulair, as well as cardiovascular drugs Vytorin and Zetia. ...
Side effects of Ezetrol - by Manura Nanayakkara MBBS - Helium: This drug is available as a combination with Simvastatin (Vytorin®). This drug should be taken at least two hours before or at least four hours after taking ...
Central Vytorin exec leaves Merck post-merger; Russia starts antitrust probe at Novo; - FiercePharma: Enrico P. Veltri, a Schering-Plough vice-president who played the central role in a controversial study of the cholesterol drug Vytorin, has left the ...
Patent Docs: Court Report: 1998) following a Paragraph IV certification as part of Mylan's filing of an ANDA to manufacture a generic version of Plaintiffs' Zetia® (ezetimib, ...
Conducive Magazine | CONCEIVE CHRONICLE CHANGE: Joint Pain With Vytorin Having closed the door lest the partiality of the egyptian queen. Octavius was making tea, and elizabeth returned instantly to jane, ...
Research and Markets: Dyslipidemia Pipeline Assessment and Market Forecasts to 2016 | Business Wire: PR Newswire (press release)
The patents of Zetia, Vyotrin, Lescol, Livalo and Lovaza are set to expire between 2012 and 2014. The market growth will be sustained by the launch of major new products with safety and convenience advantages such as once-daily ...
Patent Docs: Court Report: 1998) following a Paragraph IV certification as part of Mylan's filing of an ANDA to manufacture a generic version of Plaintiffs' Zetia® (ezetimib, used to treat elevated cholesterol levels). View the complaint here . ...
That Schering-Plough Lawsuit Isn't Going Away. In the Pipeline:: Last summer I mentioned a shareholder lawsuit against Schering-Plough over the way that the ENHANCE clinical data were handled for Vytorin. One of the interesting features here is that the plaintiffs are claiming that the company knew that the clinical ...
Merck Partners With South African Drugmaker : NPR: Its top sellers include the asthma drug Singulair, and Vytorin and Zetia for high cholesterol. The drugs will be jointly marketed by Merck's MSD South ...
????? ?? ???? ?????? ??????? | Sport 1 - ????????? ???? ?? ????????: PRIZNATI NEKADYRNICI: ZETIA, SINCHETO, BIJU-SIMULATOR, GONZO, LEGENDATA I . ????? ?????? ??????, ??????? ?? ???????? ?????? ? ?????, ?? ?? ?? ???????? ????????? ?????? ?? ????????! ??? ?? ???????: ? ? ?????? ?? ?? ?????! ...

???? ???? ? ??????? | Sport 1 - ????????? ???? ?? ????????: PRIZNATI NEKADYRNICI: ZETIA, SINCHETO, BIJU-SIMULATOR, GONZO, LEGENDATA I . ???????? ????????????? ?? ??? ????? ?? ????????? ?? ??????????? ? ????????? "????? ?? ???????????" ?? ?? ?????????? ?????????. * ??????????? ?? ??????? ???? ?? ???????????? ???????????. ...
Scandal la Teatrul Muzical cu mascati si artisti tepuiti / Balerinii Teatrului de Opera si Balet din Kiev au refuzat sa urce pe scena chiar înainte de ridicarea cortinei: Avem senzatia ca suntem pur si simplu jefuiti", ne-a declarat Tamara Zetia, impresara artistilor din Kiev. În replica, Florin Melinte infirma acuzatiile aduse si spune ca la mijloc este o neîntelegere între impresarul ucrainean si cel român, Mocanu Maftei. ...
Mixing It Up With Mixed Results (GSK): Merck also plans to combine its cholesterol drug Zetia with Pfizer's (NYSE: PFE) Lipitor once it goes off-patent. Some patients will just switch to taking two pills instead of one, but that can also increase sales, since the combo product may work better than ...
Can Red Yeast Rice Reduce Cholesterol? — Health and Fitness Times: Generally there are additionally non-statin drug treatments which lower cholesterol, like cholesterol-blocker Zetia. “It isn't really apparent if the sufferers in this research had been taking very large dosages of statins,” he states. “If they had been, their ...
American Chronicle | Glenmark puts IPO of generics arm on hold: An executive says the firm is no longer in need for money; analysts say maket conditions behind the move: Glenmark also favourably settled a litigation with Merck and Co. on cholesterol drug Zetia; this will allow Glenmark to launch the product before the expiry of the patent in 2017. Annual sales in the US in 2009 from Zetia (ezetimibe) were around $1.6 billion. ...
Canada lists the top prescription drugs Americans buy online | Booster Shots | Los Angeles Times: Flomax (an alpha-adrenergic blocker often given to men with enlarged prostates), Asacol (for inflammatory bowel disease), Nexium (an antacid), Zetia, Crestor and Lipitor (for treating high cholesterol), Synthroid (for hypothryroidism), Prandin, Januvia and Actos (all diabetes medications), Premarin (estrogen ...
Farmaci: attenzione a quelli pericolosi ancora in commercio | Tanta Salute: Anche l'associazione farmacologica di due principi attivi quali l'Ezetimibe e Simvastatina ( nome commerciale Inegy, Vytorin ) andrebbe indotto gli scienziati a ritenere una certa cautela nell’uso di tali farmaci, il motivo si riconduce ad uno studio denominato SEAS, ...
Is Merck a Buy? | The Money Times: nice selection too -- they were partners on cholesterol drugs Vytorin and Zetia -- so it's not too surprising that's where its pipeline is the fullest. The biggest potential blockbuster of the group is its blood-clot reducer, vorapaxar. Merck hopes the novel molecule ...
Merck Positioned to Drive Growth Through Innovative Portfolio, Pipeline and Strategy for Growth in Emerging Markets | Vadvert - UK Paid Press Release Distribution Service: ISENTRESS (raltegravir) and ZETIA (ezetimibe)/VYTORIN (ezetimibe/simvastatin) as well as flawless execution of near-term potential launches following regulatory approvals for boceprevir, vorapaxar, TREDAPTIVE (ER niacin/laropiprant) and odanacatib. These products have the potential to change the current ...
OfficialWire: Schering-Plough: Pipeline, Products, Performance And Potential - New Company Profile Published: Furthermore, Zetia and Vytorin, the key components of the Schering-Plough/Merck & Co cholesterol joint venture, will make an increasingly strong contribution to pharmaceutical revenue. In addition, Schering-Plough has historically sought regulatory approval to switch prescription products to OTC status ...

Want to contact a District of Columbia Vytorin lawyer? ...Get a free case evaluation from one of our District of Columbia Vytorin lawyers now.

Pages: Previous 1 2 3 4 5 6 7 8 9 10 11 Next

Need A Vytorin Attorney?

First Name Last Name Email Address State

Legal Issue

Unsafe Drugs: Vytorin Click to select a Legal Issue

Was Your Health Negatively Affected?

Please Describe the Injury

close this window

Vytorin Information

Click to View Our Legal Resources

Want to contact a District of Columbia Vytorin lawyer? ...Get a free case evaluation from one of our District of Columbia Vytorin lawyers now.

Looking for a Vytorin lawyer? LegalView.info provides information for the cholesterol medication Vytorin, Vytorin side effects, Vytorin problems, including cardiovascular complications such as heart attacks, and recent reports that question whether Vytorin is ineffective. Find information on a Vytorin settlement, Vytorin news, a Vytorin verdict, a possible Vytorin recall, a possible Vytorin class action lawsuit and updated Vytorin litigation for those seeking information about a Vytorin lawsuit. Individuals who have or are currently taking the prescription drug Vytorin may be able to seek Vytorin lawyers and Vytorin attorneys to help pursue a Vytorin trial or a Vytorin law suit. LegalView.info has services to help you find a Vytorin attorney from a respected law firm in your area. For additional information on Vytorin law, information about your legal rights, or if you feel you have a Vytorin case, please complete a Vytorin claim form for a free case evaluation.

LegalView.info is sponsored by law firms with offices in many states. This website contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Your access to this site does not constitute a legal attorney-client relationship. The choice of a lawyer is an important decision and should not be based solely upon advertisements. To access important information concerning the sponsors and their commitment to the ethical practice of law, click here.

The participating law firms are as follows: Anapol Schwartz (Philadelphia, Pennsylvania; Cherry Hill, New Jersey; Media, Pennsylvania; Reading, Pennsylvania; Wheeling, WV). Cohen, Placitella & Roth (Red Bank, New Jersey; Philadelphia, Pennsylvania). J. F. Humphreys (Charleston, West Virginia). Lopez McHugh (Newport Beach, California; Philadelphia, PA; and Moorestown, NJ). Click here for more information about these law firms.

Some of our partner firms do not accept some types of cases. For details on these case exceptions, click here.

20120517-200403

Close (x)

Looking for an Attorney?

Please type your question:

First Name:
Last Name:
E-mail:
Phone Number *
() -

State * Legal Issue *

Unsafe Drugs: Vytorin Click to select a Legal Issue

Close (x)

Find Legal Help for Your Vytorin Case - Submit Your Information Below

Do you need legal assistance with your Vytorin case?
LegalView may be able to help.

Submit your information below for a free, no-cost evaluation.

We'll submit your information to one of our partner firms.
LegalView's partners represent clients throughout the United States, for a very wide range of legal issues. Submit your information now, to see if one of LegalView's partners can help!

* Indicates Required Fields

First name *

Last name *

Email Address *

Phone Number *
() -

State *

Legal Issue * Unsafe Drugs: Vytorin Change

Was There an Injury?

Please Describe The Injury

Please State Your Question *

DISCLAIMER and STATEMENT OF NON-CONFIDENTIALITY

By submitting this form, you agree that completing the above is not intended to create an attorney-client relationship.

Disclosure

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website, LegalWebMedia.com will submit your information to the law firms that pay for this group advertising and to respond to your requests for information concerning legal services in their assigned local areas. If there is no sponsoring firm in your state, your inquiry will be submitted to one of the sponsoring law firms on a predetermined, rotating basis. If the sponsoring law firm accepts your case, it will associate with licensed attorneys practicing in your state, if required; the sponsoring law firm may also contact other law firms to see if they may be able to assist.

The information provided by the LegalView.com and LegalWebMedia.com websites is for advertising and informational purposes and should not be considered as legal advice from the sponsoring attorneys. The websites contain general information and may not reflect current legal developments, verdicts, or settlements. LegalView.com contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Any person viewing or receiving information from these websites should not act or refrain from acting on the basis of any such information without first seeking appropriate legal advice from an attorney in your area. Legal WebTV Network, LLC expressly disclaims any liability with respect to actions taken or not taken by the recipient based on any or all of the information or contents contained in these websites.

Any information sent to Legal WebTV Network LLC through this website is done using standard Web encryption techology. LegalView.com will exercise all reasonable care, within technological limits, to protect the confidentiality of any information submitted via Internet e-mail or through this website. By accessing this website, you may be seeking an attorney to represent you or legal advice. However, none of the sponsoring attorneys represent you yet.

The choice of a lawyer is an important decision and should not be based solely upon advertisements.

Any transmission of information, whether via Internet e-mail or through the website, is solely for evaluation purposes by the sponsoring law firms and their associates. The transmission of any information to any attorney sponsoring advertising on LegalView.com or LegalWebMedia.com does not create an attorney-client relationship between the sender and any recipient. An attorney-client relationship can only be created by a written, signed-fee agreement entered into with an attorney. The sponsoring attorneys will treat your information as a confidential communication for the purpose of obtaining legal services or legal advice.

For more information about the sponsoring law firms, please click here.

This form is secure and encrypted. More information about secure forms and your privacy here.